Richard Glickman

Executive

CA·SEDI

enGene Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 18 Jun 2026 for enGene Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Richard Glickman: trading record in brief

Only one filing by Richard Glickman is known so far (18 June 2026): an option exercise, in enGene Therapeutics Inc. That is too little to draw conclusions. Source: insider filings from SEDI. Past trades are no guide to future returns.

Companies and markets linked to Richard Glickman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

enGene Therapeutics Inc. (CA)

Declarations1 total

◇

Richard Glickman

4 - Director of IssuerExecutives16 Jun 2026enGene Therapeutics Inc.

0SEDI ↗

31,000 sharesOptionsTSXSEDI:4737405

1 of 1 declaration

Richard Glickman

Insider track record

Richard Glickman: trading record in brief

Companies and markets linked to Richard Glickman

Related entities

Richard Glickman

Insider track record

Richard Glickman: trading record in brief

Companies and markets linked to Richard Glickman

Related entities